Kharroubi Akram, Saba Elias, Smoom Riham, Bader Khaldoun, Darwish Hisham
Faculty of Health Professions, Al-Quds University, Jerusalem, Palestine.
Palestinian Osteoporosis Prevention Society [POPS], Bethlehem, Palestine.
Arch Osteoporos. 2017 Dec;12(1):13. doi: 10.1007/s11657-017-0306-7. Epub 2017 Jan 26.
This study evaluated the association of vitamin D and bone markers with the development osteoporosis in Palestinian postmenopausal women. Even though vitamin D deficiency was very high for the recruited subjects, it was not associated with osteoporosis except for bones of the hip. Age and obesity were the strongest determining factors of the disease.
The purpose of this study was to investigate the association of bone mineral density (BMD) with serum vitamin D levels, parathyroid hormone (PTH), calcium, obesity, and bone turnover markers in Palestinian postmenopausal women.
Three hundred eighty-two postmenopausal women (≥45 years) were recruited from various women clinics for BMD assessment (131 women had osteoporosis and 251 were normal and served as controls). Blood samples were obtained for serum calcium, PTH, 25(OH)D, bone formation (N-terminal propeptide (PINP)), and bone resorption (serum C-terminal telopeptide of type I collagen (CTX1)) markers.
Women with osteoporosis had statistically significant lower mean weight, height, body mass index (BMI), and serum calcium (p < 0.05) compared to controls. No significant differences were detected between the mean values of bone turnover markers (CTX and PINP), 25(OH)D, and PTH of the two groups. Women with vitamin D deficiency (severe and insufficiency) represented 85.9% of the study subjects. Multiple and logistic regression showed that age and BMI significantly affected BMD and vitamin D had a significant association with BMD only at the lumbar spine. BMI was positively correlated with BMD and PTH but negatively correlated with vitamin D. Logistic regression showed that the odds ratio (OR) for having osteoporosis decreased with increasing BMI (overweight OR = 0.11, p = 0.053; obese OR = 0.05, p = 0.007).
There was no direct correlation between BMD and PTH, bone turnover markers, and vitamin D except at the lumbar spine. A negative correlation between BMD and age and a positive correlation with BMI were observed. The protective effect of obesity on osteoporosis was complicated by the effect of obesity on vitamin D and PTH.
本研究评估了巴勒斯坦绝经后女性中维生素D和骨标志物与骨质疏松症发生之间的关联。尽管招募对象中维生素D缺乏率很高,但除髋骨外,维生素D缺乏与骨质疏松症并无关联。年龄和肥胖是该疾病最强的决定因素。
本研究旨在调查巴勒斯坦绝经后女性的骨矿物质密度(BMD)与血清维生素D水平、甲状旁腺激素(PTH)、钙、肥胖及骨转换标志物之间的关联。
从多家妇女诊所招募了382名绝经后女性(≥45岁)进行骨密度评估(131名女性患有骨质疏松症,251名正常女性作为对照)。采集血样检测血清钙、PTH、25(OH)D、骨形成标志物(N端前肽(PINP))和骨吸收标志物(血清I型胶原C端肽(CTX1))。
与对照组相比,患有骨质疏松症的女性平均体重、身高、体重指数(BMI)和血清钙在统计学上显著更低(p < 0.05)。两组的骨转换标志物(CTX和PINP)、25(OH)D和PTH平均值之间未检测到显著差异。维生素D缺乏(严重缺乏和不足)的女性占研究对象的85.9%。多元和逻辑回归显示,年龄和BMI显著影响骨密度,维生素D仅在腰椎与骨密度有显著关联。BMI与骨密度和PTH呈正相关,但与维生素D呈负相关。逻辑回归显示,患骨质疏松症的比值比(OR)随BMI增加而降低(超重OR = 0.11, p = 0.053;肥胖OR = 0.05, p = 0.007)。
除腰椎外,骨密度与PTH、骨转换标志物和维生素D之间无直接关联。观察到骨密度与年龄呈负相关,与BMI呈正相关。肥胖对骨质疏松症的保护作用因肥胖对维生素D和PTH的影响而变得复杂。